newdrugapprovals.org
Pacritinib
Pacritinib A Jak2 inhibitor potentially for the treatment of acute myeloid Leukemia and myelofibrosis. ONX-0803; SB-1518 CAS No. 937272-79-2 472.57868 g/mol, C28H32N4O3 S*Bio Pte Ltd. and co…